CROM Workshop May 2022 Recording

VIEW FULL SCREEN

Non-combusted tobacco products are increasingly seen as having potential for harm reduction. Yet, smokers often harbor misperceptions about their risks relative to conventional cigarettes, which impede their transitioning to lower-risk products such as ENDS. This makes communication of accurate relative-risk information important. Accordingly, in some jurisdictions, regulations include provisions for communicating accurate risk information to potential consumers. To ensure effective, accurate, and not misleading communication, regulators may require extensive testing of risk-messaging to ensure appropriate impact on various populations. The US FDA’s Modified-Risk Tobacco Product Application (MRTPA) process required for claims is a prominent example.
 
MRTPA claim testing studies and other related tobacco product perception and intention studies (TPPIS) rely on consumer-reported outcome measures (CROM) as key endpoints, and thus can illustrate the methodological considerations in using such measures in regulatory applications. This workshop brings out some of these considerations, exploring them within the context of a recently executed MRTPA Claims Testing study.

Programme and Speakers

• Introduction
    Christelle CHREA, PhD, Philip Morris Products (and CROM Consortium Coordinator)
• Claim Comprehension and Intention Study for JUUL E-cigarette Products: Findings and CROM-Related Measurement
    Stacey McCAFFREY, PhD, JUUL Labs Inc. & Saul SHIFFMAN, PhD, Pinney Associates
• Break
• Audience Q&A
• Closing Remarks
    Christelle CHREA, PhD, Philip Morris Products (and CROM Consortium Coordinator)